4//SEC Filing
RIGEL PHARMACEUTICALS INC 4
Accession 0001179110-17-010231
$RIGLCIK 0001034842operating
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:39 PM ET
Size
5.3 KB
Accession
0001179110-17-010231
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-07-05$2.69/sh−5,000$13,427→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016.
- [F2]The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001034842
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:39 PM ET
- Size
- 5.3 KB